Display options
Share it on

Front Neurosci. 2017 Apr 21;11:192. doi: 10.3389/fnins.2017.00192. eCollection 2017.

Molecular Chaperone Accumulation in Cancer and Decrease in Alzheimer's Disease: The Potential Roles of HSF1.

Frontiers in neuroscience

Stuart K Calderwood, Ayesha Murshid

Affiliations

  1. Molecular and Cellular Radiation Oncology, Beth Israel Deaconess Medical Center, Center for Life Sciences 610, Harvard Medical SchoolBoston, MA, USA.

PMID: 28484363 PMCID: PMC5399083 DOI: 10.3389/fnins.2017.00192

Abstract

Molecular chaperones are required to maintain the proteome in a folded and functional state. When challenges to intracellular folding occur, the heat shock response is triggered, leading to increased synthesis of a class of inducible chaperones known as heat shock proteins (HSP). Although HSP synthesis is known to undergo a general decline in most cells with aging, the extent of this process varies quite markedly in some of the diseases associated with advanced age. In Alzheimer's disease (AD), a prevalent protein folding disorder in the brain, the heat shock response of some critical classes of neurons becomes reduced. The resulting decline in HSP expression may be a consequence of the general enfeeblement of many aspects of cell physiology with aging and/or a response to the pathological changes in metabolism observed specifically in AD. Cancer cells, in contrast to normal aging cells, undergo

Keywords: Alzheimer's disease; cancer; heat shock protein; molecular chaperone; proteotoxic stress

References

  1. ACS Chem Biol. 2012 Oct 19;7(10):1677-86 - PubMed
  2. J Alzheimers Dis. 2013;33 Suppl 1:S123-39 - PubMed
  3. Biochemistry. 2013 Sep 17;52(37):6445-55 - PubMed
  4. Oncogene. 2015 Apr 23;34(17):2178-88 - PubMed
  5. J Neurochem. 2008 Mar;104(6):1433-9 - PubMed
  6. J Biol Chem. 1996 Nov 29;271(48):30847-57 - PubMed
  7. Mol Cell Biol. 1991 Jun;11(6):3365-8 - PubMed
  8. Annu Rev Pathol. 2009;4:127-50 - PubMed
  9. Oncogene. 2015 Oct;34(43):5460-71 - PubMed
  10. PLoS One. 2012;7(6):e39679 - PubMed
  11. Cytokine. 1999 May;11(5):347-58 - PubMed
  12. Mol Cell. 2010 Oct 22;40(2):253-66 - PubMed
  13. Mol Cell Biol. 1996 Mar;16(3):839-46 - PubMed
  14. Biochem Cell Biol. 2009 Dec;87(6):845-51 - PubMed
  15. Arch Toxicol. 2013 Jan;87(1):19-48 - PubMed
  16. Mol Cell Biol. 1995 Jun;15(6):3354-62 - PubMed
  17. J Neurosci Res. 2008 Sep;86(12):2763-73 - PubMed
  18. Cell. 1998 Aug 21;94(4):471-80 - PubMed
  19. Annu Rev Genet. 1988;22:631-77 - PubMed
  20. Cancer Res. 2014 Sep 1;74(17 ):4731-40 - PubMed
  21. J Biol Chem. 2006 Jan 13;281(2):782-91 - PubMed
  22. Nat Med. 1996 Jul;2(7):783-7 - PubMed
  23. Biomed Res Int. 2014;2014:495091 - PubMed
  24. Adv Exp Med Biol. 2007;594:1-13 - PubMed
  25. Elife. 2016 Nov 10;5:null - PubMed
  26. Cancer Res. 1980 Dec;40(12):4501-8 - PubMed
  27. Trends Biochem Sci. 2016 Apr;41(4):311-23 - PubMed
  28. EMBO J. 2008 Jan 23;27(2):336-49 - PubMed
  29. Brain Res. 2013 Jun 26;1519:105-11 - PubMed
  30. Biochim Biophys Acta. 2008 Aug;1779(8):507-21 - PubMed
  31. Scientifica (Cairo). 2013;2013:217513 - PubMed
  32. Int J Cell Biol. 2014;2014:217371 - PubMed
  33. Mol Cell Biol. 2006 Feb;26(3):955-64 - PubMed
  34. Crit Rev Eukaryot Gene Expr. 1994;4(4):357-401 - PubMed
  35. Int J Hyperthermia. 2011;27(5):409-14 - PubMed
  36. Cell Rep. 2014 Nov 6;9(3):1135-50 - PubMed
  37. Mol Neurobiol. 2014 Feb;49(1):120-35 - PubMed
  38. Cancer Res. 2007 Mar 1;67(5):2373-81 - PubMed
  39. J Neurosci. 2010 Nov 17;30(46):15374-82 - PubMed
  40. Cell. 2011 Mar 4;144(5):646-74 - PubMed
  41. Oncogene. 2008 Mar 20;27(13):1886-93 - PubMed
  42. Neurology. 2005 Mar 8;64(5):895-8 - PubMed
  43. Biogerontology. 2014 Dec;15(6):547-57 - PubMed
  44. J Neuropathol Exp Neurol. 2009 Jan;68(1):48-58 - PubMed
  45. Cell. 2013 Jun 6;153(6):1194-217 - PubMed
  46. Mol Cell. 2008 Jul 25;31(2):222-31 - PubMed
  47. Cell Cycle. 2006 Nov;5(22):2592-601 - PubMed
  48. Curr Protein Pept Sci. 2012 Feb;13(1):86-103 - PubMed
  49. Oncogene. 2011 Jun 23;30(25):2836-45 - PubMed
  50. Hum Mol Genet. 2016 Jan 15;25(2):211-22 - PubMed
  51. PLoS One. 2011;6(12):e28950 - PubMed
  52. J Neurosci. 2003 Jul 2;23 (13):5789-98 - PubMed
  53. Cell Stress Chaperones. 2005 Summer;10(2):86-103 - PubMed
  54. Sign Transduct Insights. 2010;2:13-24 - PubMed
  55. Nat Commun. 2015 Sep 18;6:8308 - PubMed
  56. Mol Cell. 1998 Jul;2(1):101-8 - PubMed
  57. Ann N Y Acad Sci. 2007 Oct;1113:202-16 - PubMed
  58. Cell. 2014 Jun 19;157(7):1685-97 - PubMed
  59. FASEB J. 2013 Oct;27(10):4169-83 - PubMed
  60. Mol Cell Pharmacol. 2010 Jan 1;2(2):43-46 - PubMed
  61. Science. 1992 Mar 6;255(5049):1243-5 - PubMed
  62. Annu Rev Cell Dev Biol. 1995;11:441-69 - PubMed
  63. J Neurosci. 2014 May 21;34(21):7253-65 - PubMed
  64. Science. 2009 Feb 20;323(5917):1063-6 - PubMed
  65. Gerontology. 2009;55(5):550-8 - PubMed
  66. Nat Rev Mol Cell Biol. 2010 Aug;11(8):545-55 - PubMed
  67. Front Mol Neurosci. 2011 Aug 26;4:17 - PubMed
  68. Science. 2003 May 16;300(5622):1142-5 - PubMed
  69. Mol Cell Biol. 2003 Sep;23 (17 ):6013-26 - PubMed
  70. J Biol Chem. 1998 Jul 17;273(29):18640-6 - PubMed
  71. Aging Cell. 2008 Jun;7(3):394-404 - PubMed
  72. Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4376-85 - PubMed
  73. PLoS One. 2008 Feb 13;3(2):e1598 - PubMed
  74. J Struct Biol. 2000 Jun;130(2-3):88-98 - PubMed
  75. Oncogene. 2008 Sep 18;27(41):5497-510 - PubMed
  76. Oncogene. 2005 Sep 29;24(43):6564-73 - PubMed
  77. Biophys J. 2013 Oct 15;105(8):1778-85 - PubMed
  78. Neuron. 2001 Jan;29(1):15-32 - PubMed
  79. J Mol Biol. 2015 Apr 10;427(7):1644-54 - PubMed

Publication Types

Grant support